Bunzl picks up Gisa in Mexico and Quindesur in Spain
Bunzl has announced two new bolt-on acquisitions and confirmed completion of two previously announced deals. In Spain, it has acquired Quindesur, a distributor focused on foodservice and cleaning & hygiene in Southern Spain. In Mexico, it has completed the purchase of Guantes Internacionales, S.A. de C.V. (Gisa), a leading own brand distributor of personal protective equipment with a strong emphasis on gloves.
Two more deals – Solupack in Brazil and Hospitalia in Chile – have now completed following announcements earlier this year. The CEO describes Gisa and Quindesur as the fourth and fifth acquisitions of 2025, keeping Bunzl’s long-running buy-and-build strategy very much on the front foot.
Key figures and deal snapshot
| Company | Country | Focus | 2024 Revenue | Status |
|---|---|---|---|---|
| Quindesur | Spain | Foodservice; Cleaning & Hygiene | EUR 14 million (c.£12 million) | Completed (July 2025) |
| Gisa | Mexico | PPE – gloves; own brand | MXN 399 million (c.£17 million) | Completed (August 2025) |
| Solupack | Brazil | Own brand packaging for food industry | Not disclosed | Completed (July 2025) |
| Hospitalia | Chile | Healthcare distribution | Not disclosed | Completed (July 2025) |
- Gisa offers strong cross-selling opportunities with Bunzl’s existing businesses in the US and Mexico.
- Quindesur strengthens Bunzl’s regional presence in Southern Spain and complements existing operations.
- Since 2004, Bunzl has committed more than £6 billion across more than 230 acquisitions.
- The acquisition pipeline remains active, according to the CEO.
Why these buys matter for Bunzl’s growth model
These are classic Bunzl deals: targeted, category-focused and regionally complementary. Quindesur deepens coverage in Spain in two core categories where Bunzl already plays, which should help route density and service levels. Gisa plugs into PPE – a category where own brand can be a differentiator – and has immediate cross-selling potential into Bunzl’s existing customer base across North America and Mexico.
The completion of Solupack and Hospitalia extends the Latin American footprint across Brazil and Chile, adding packaging and healthcare exposure. Put together, this is Bunzl broadening both geography and product mix, while leaning into its compounding growth model through bolt-on M&A.
Scale and likely impact – small bolt-ons with strategic angles
With disclosed 2024 revenues of around £12 million for Quindesur and around £17 million for Gisa, these look like bolt-on acquisitions rather than transformational changes. That is very much in character for Bunzl, which typically buys, integrates and optimises rather than swinging for the fences.
The strategic kicker here is twofold. First, Gisa’s glove-led PPE proposition in Mexico should travel well through Bunzl’s existing channels, especially given the US and Mexico footprint highlighted in the RNS. Second, Quindesur strengthens density in Southern Spain, which can improve delivery efficiencies and customer retention in foodservice and cleaning & hygiene.
Reading the RNS: what’s disclosed and what isn’t
What we know
- Two acquisitions completed: Quindesur in July and Gisa in August.
- Two previously announced acquisitions, Solupack and Hospitalia, completed in July.
- Quindesur 2024 revenue: EUR 14 million (c.£12 million).
- Gisa 2024 revenue: MXN 399 million (c.£17 million).
- Gisa has cross-selling opportunities with Bunzl’s US and Mexico businesses.
- Since 2004, Bunzl has committed more than £6 billion across more than 230 acquisitions.
Not disclosed
- Purchase prices and consideration structure.
- Valuation multiples and expected returns on invested capital.
- Profitability or margin profiles of the acquired businesses.
- Earnings per share impact, synergy targets and integration costs.
- Any change to guidance or outlook – not disclosed.
Strategic fit: where the synergies could show up
- PPE cross-sell: Gloves are a staple in industrial and food handling settings. Gisa’s own brand PPE should be portable across customer segments in Mexico and adjacent US markets, potentially boosting volumes without proportionate overhead growth.
- Route density in Spain: Adding Quindesur can tighten logistics in Southern Spain, widening the SKU range per drop and improving service while spreading fixed costs.
- Own brand exposure: Both Gisa and Solupack emphasise own brand solutions. Own brand can help with differentiation and price positioning, which is useful in competitive categories.
- LatAm platform building: Brazil, Chile and Mexico now feature in the 2025 deal flow alongside Spain. That is meaningful for geographical diversification and long-term optionality.
Risks and watchouts for investors
- Integration complexity: Four completions across Spain, Mexico, Brazil and Chile in quick succession increases execution demands on local management teams.
- Currency volatility: Revenues are in EUR and MXN for the disclosed deals, with BRL and CLP exposure implied by completions in Brazil and Chile. FX movements can influence reported performance in sterling.
- Supply chain and customer retention: Realising cross-sell benefits depends on integrating systems, aligning supplier terms and keeping key customers happy during the transition.
- Unknown economics: With no purchase prices or margin data, it is hard to judge deal returns at this stage.
My take: steady execution, sensible bolt-ons
This is Bunzl doing what it does best – layering in modest, targeted acquisitions that broaden reach and deepen category presence. The disclosed revenues suggest these are small deals in the context of the Group, but they carry clear strategic logic, particularly the PPE cross-selling potential from Gisa and the regional strengthening in Spain via Quindesur.
The absence of pricing, margins or EPS guidance is normal for Bunzl’s RNS style, so investors will need to wait for interim or full-year updates to see the early economic impact. For now, the message is continuity: a busy pipeline, disciplined deployment and yet more proof that the compounding acquisition engine is still running.
Net positive on strategy and portfolio quality, with the usual caveat that execution and FX will do some of the heavy lifting from here.